Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» enobosarm
enobosarm
Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.
BioPharma Dive
Fri, 10/11/24 - 11:10 am
Novo Nordisk
Eli Lilly
obesity
Zebound
Wegovy
CagriSema
Amgen
MariTide
oforglipron
Veru
enobosarm
nimacimab
Skye Bioscience
Veru touts novel breast cancer treatment strategy as drug nears phase 3
Fierce Biotech
Thu, 01/21/21 - 11:27 pm
Veru
clinical trials
enobosarm
breast cancer
GTx reports results from Phase 2 study of enobosarm
Yahoo/Fly on the Wall
Mon, 06/2/14 - 02:58 pm
GTx
enobosarm
breast cancer
metastatic breast cancer
ASCO
GTx says current POWER trials data insufficient to support filing NDA
The Fly on the Wall
Thu, 05/8/14 - 11:23 am
GTx
enobosarm
non-small cell lung cancer
GTx says muscle drug fails in late-stage trials
Reuters
Mon, 08/19/13 - 09:48 am
GTx
enobosarm
cancer-induced muscle wasting
MannKind, Vical, GTx: Investors Predict Pivotal Clinical Trial Results
TheStreet.com
Mon, 08/5/13 - 07:23 am
MannKind
Vical
clinical trials
GTx
diabetes
Afrezza
melanoma
Allovectin-7
enobosarm
lung cancer-related muscle wasting
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:41 am
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
PSivida Corporation And GTx: 2 Of The Most Undervalued Biotechs For 2013
Seeking Alpha
Mon, 05/20/13 - 11:23 am
pSivida
GTx
Iluvien
enobosarm
GTx And Trius Therapeutics: 2 Top Biotech Buys For 2013
Seeking Alpha
Thu, 04/18/13 - 08:05 am
GTx
Trius Therapeutics
enobosarm
TR-701
FDA designates GTx's enobosarm as Fast Track development program
Yahoo/Fly on the Wall
Tue, 01/8/13 - 10:38 am
FDA
GTx
enobosarm
fast track
non-small cell lung cancer